Building global development strategies for cf therapeutics during a transitional cftr modulator era

N. Mayer-Hamblett*, S. van Koningsbruggen-Rietschel, D. P. Nichols, D. R. VanDevanter, J. C. Davies, T. Lee, A. G. Durmowicz, F. Ratjen, M. W. Konstan, K. Pearson, S. C. Bell, J. P. Clancy, J. L. Taylor-Cousar, K. De Boeck, S. H. Donaldson, D. G. Downey, P. A. Flume, P. Drevinek, C. H. Goss, I. FajacA. S. Magaret, B. S. Quon, S. M. Singleton, J. M. VanDalfsen, G. Z. Retsch-Bogart

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)

Fingerprint Dive into the research topics of 'Building global development strategies for cf therapeutics during a transitional cftr modulator era'. Together they form a unique fingerprint.

Medicine & Life Sciences